U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07110818) titled 'Non-ischemic Cardiomyopathy Registry, Biobank and Imaging Data Repository' on June 03.
Brief Summary: The main goal of CaNICM is to create a central database that includes a biobank and an imaging data repository for patients with non-ischemic cardiomyopathy (NICM), as well as for at-risk family members. This includes people who carry rare genetic variants linked to NICM but do not show symptoms, and first-degree relatives.
The specific goals of this database and biobank are to:
Improve how we predict the risk of heart rhythm problems in NICM patients. Improve how and when we screen family members who might carry the disease - who ...